Expression of the P-protein of the human hepatitis B virus in a vaccinia virus system and detection of the nucleocapsid-associated P-gene product by radiolabelling at newly introduced phosphorylation sites
- 1 January 1992
- journal article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 20 (2) , 195-202
- https://doi.org/10.1093/nar/20.2.195
Abstract
Hepatitis B virus (HBV) contains a particle-associated DNA polymerase/reverse transcriptase activity encoded by the P (pol) open reading frame. Due to its low abundance, the corresponding protein has so far escaped direct detection and structural analysis. As a first step to overcome these difficulties, a series of recombinant vaccinia viruses was constructed and used for the synthesis in human hepatoma cells of both the authentic full length protein and of its functional domains. Pulse chase experiments demonstrated that the P-proteins had very short half lives in striking contrast to the viral core protein expressed in parallel with the same system. No evidence was obtained for a specific proteolytic processing of the P-protein as occurring with retroviral pol gene products. Overexpression of P-protein by recombinant vaccinia viruses was then employed to develop a highly sensitive detection method based on the in vitro phosphorylation of newly introduced target sites for protein kinase A. The usefulness of this method was demonstrated in the analysis of encapsidated P-gene products that were transiently expressed from an appropriately modified HBV genome. The results obtained indicate that the P-protein acts unprocessed, at least during the initial steps of nucleocapsid assembly and reverse transcription, and that a fraction of the P-protein molecules is linked as such to the viral DNA. Direct detection of the hepadnaviral P-protein by in vitro phosphorylation should greatly facilitate future analyses on P-protein structure and function.Keywords
This publication has 18 references indexed in Scilit:
- Phosphorylation and rapid turnover of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus.1991
- Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.Proceedings of the National Academy of Sciences, 1991
- Translational inactivation of RNA function: Discrimination against a subset of genomic transcripts during HBV nucleocapsid assemblyCell, 1990
- High expression of functional adenovirus DNA polymerase and precursor terminal protein using recombinant vaccinia virusNucleic Acids Research, 1988
- PROTEIN SERINE/THREONINE KINASESAnnual Review of Biochemistry, 1987
- Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.Molecular and Cellular Biology, 1985
- Oligonucleotide-Directed Mutagenesis: A Simple Method Using Two Oligonucleotide Primers and a Single-Stranded DNA TemplateDNA, 1984
- Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediatePublished by Elsevier ,1982
- Hepatitis B virus genes and their expression in E. coliNature, 1979
- Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell lineNature, 1979